ARD001
/ Arditus
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 27, 2026
A First-in Human Study of ARD001 in Healthy Volunteers and People With Hemophilia A
(clinicaltrials.gov)
- P1/2 | N=20 | Recruiting | Sponsor: Arditus Pte Ltd
First-in-human • New P1/2 trial • Hematological Disorders • Hemophilia • Hemophilia A • Rare Diseases
1 to 1
Of
1
Go to page
1